Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Jericho Sciences

other

www.jerichosciences.comDurham (RTP), North Carolina, United States
2 profile visits

About

Jericho Sciences is developing small molecule antiviral therapeutics to address both chronic virus infections and potential emerging viruses, with current focus on a curative approach for clearing chronic Hepatitis B Virus infection — a leading cause of all liver diseases — with morbidities and mortalities affecting an estimated 3.6 million people in the EU and UK (300 million globally).

What is your business/industry sector?

Biotech, Pharma and Cosmetics

Representatives

Heidi Kay

CEO/Founder

Jericho Sciences